Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | NRAS |
Variant | Q61L |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | NRAS Q61L is a hotspot mutation that lies within a GTP-binding region of the Nras protein (UniProt.org). Q61L results in increase Erk and Mek phosphorylation, and activation of Ck2alpha in cell culture (PMID: 27251789), and is predicted to lead to a loss of Nras protein function based on the effects of HRAS Q61L (PMID: 23487764) and KRAS Q61L (PMID: 26037647). |
Associated Drug Resistance | |
Category Variants Paths |
NRAS mutant NRAS act mut NRAS Q61L NRAS mutant NRAS exon3 NRAS Q61X NRAS Q61L |
Transcript | NM_002524.5 |
gDNA | chr1:g.114713908T>A |
cDNA | c.182A>T |
Protein | p.Q61L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002524.4 | chr1:g.114713908T>A | c.182A>T | p.Q61L | RefSeq | GRCh38/hg38 |
NM_002524 | chr1:g.114713908T>A | c.182A>T | p.Q61L | RefSeq | GRCh38/hg38 |
NM_002524.5 | chr1:g.114713908T>A | c.182A>T | p.Q61L | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|